Comprehensive clinical and genetic characterization of hyperprogressive biliary tract cancer during PD-1 blockade monotherapy: case report and literature review.
Saved in:
| Title: | Comprehensive clinical and genetic characterization of hyperprogressive biliary tract cancer during PD-1 blockade monotherapy: case report and literature review. |
|---|---|
| Authors: | Wang KX; Department of Oncology, The Affiliated Nanjing Pukou People's Hospital of Jiangsu Health Vocational College, Nanjing Pukou People's Hospital, Liangjiang Hospital Southeast University, Nanjing, 211800, China., Yang XD; Department of General Surgery, Nanjing Pukou People's Hospital, Liangjiang Hospital Southeast University, Nanjing, 211800, China., Guo F; Department of Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, 215001, China., Sun H; Department of Oncology, The Affiliated Nanjing Pukou People's Hospital of Jiangsu Health Vocational College, Nanjing Pukou People's Hospital, Liangjiang Hospital Southeast University, Nanjing, 211800, China., Fang YY; Department of Oncology, The Affiliated Nanjing Pukou People's Hospital of Jiangsu Health Vocational College, Nanjing Pukou People's Hospital, Liangjiang Hospital Southeast University, Nanjing, 211800, China., Jiang NY; Department of Oncology, The Affiliated Nanjing Pukou People's Hospital of Jiangsu Health Vocational College, Nanjing Pukou People's Hospital, Liangjiang Hospital Southeast University, Nanjing, 211800, China., Chen XF; Department of Oncology, The Affiliated Nanjing Pukou People's Hospital of Jiangsu Health Vocational College, Nanjing Pukou People's Hospital, Liangjiang Hospital Southeast University, Nanjing, 211800, China. chenxiaofengnjmu@163.com.; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. chenxiaofengnjmu@163.com.; Gastric Cancer Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. chenxiaofengnjmu@163.com.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, 210029, China. chenxiaofengnjmu@163.com. |
| Source: | BMC medical genomics [BMC Med Genomics] 2025 Mar 14; Vol. 18 (1), pp. 52. Date of Electronic Publication: 2025 Mar 14. |
| Publication Type: | Journal Article; Case Reports; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-8794 (Electronic) Linking ISSN: 17558794 NLM ISO Abbreviation: BMC Med Genomics Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
